U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Brief: 89Bio Inc - On August 10, Gregory Grunberg Notified Board Of His Intent To Resign As A Member Of Board
89Bio Inc reports results for the quarter ended in June - Earnings Summary
Brief: 89bio, Inc. Q2 basic EPS USD -0.52
89Bio Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Rio Tinto, BurgerFi International, Aclaris Therapeutics
U.S. STOCKS ON THE MOVE-Comerica, copper miners, Journey Medical
89Bio up as Evercore starts with 'outperform', says NASH asset undervalued
Brief: 89Bio Initiates Phase 3 Entrust Trial Of Pegozafermin In Patients With Severe Hypertriglyceridemia (SHTG)
89Bio Inc reports results for the quarter ended in March - Earnings Summary
Health Rounds: New fatty liver drug shows promise in monkeys
U.S. RESEARCH ROUNDUP- Enliven Therapeutics, Lululemon Athletica, Walgreens
Brief: 89Bio Inc - Files Prospectus For Offering Of Up To 16.9 Million Shares Of Common Stock
U.S. STOCKS ON THE MOVE-CalciMedica, Natgas firms,
U.S. STOCKS ON THE MOVE-ReNew Energy, First Horizon, Block Inc
U.S. STOCKS ON THE MOVE-Incyte Corp, Netflix Inc, Comerica Inc
89Bio lifts after pricing upsized $275 mln stock offering
Brief: 89Bio Inc Announces Upsized Pricing Of $275 Million Public Offering Of Common Stock
89Bio soars to 16-month high ahead of planned equity raise